FUS Antibodies

Martinez-Macias, Moore, Green, Gomez-Herreros, Naumann, Hermann, Van Damme, Hafezparast, Caldecott: "FUS (fused in sarcoma) is a component of the cellular response to topoisomerase I-induced DNA breakage and transcriptional stress." in: Life science alliance, Vol. 2, Issue 2, (2019) (PubMed).

Singatulina, Hamon, Sukhanova, Desforges, Joshi, Bouhss, Lavrik, Pastré: "PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA." in: Cell reports, Vol. 27, Issue 6, pp. 1809-1821.e5, (2019) (PubMed).

Mori, Honda, Ishii, Yoshimura, Sasagasako, Suzuki, Taniwaki, Iwaki: "Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease." in: Neuropathology : official journal of the Japanese Society of Neuropathology, Vol. 39, Issue 5, pp. 358-367, (2019) (PubMed).

Gittings, Foti, Benson, Gami-Patel, Isaacs, Lashley: "Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS." in: Acta neuropathologica communications, Vol. 7, Issue 1, pp. 18, (2019) (PubMed).

Li, Song, Moh, Kim, Kim: "Cytoplasmic Restriction of Mutated SOD1 Impairs the DNA Repair Process in Spinal Cord Neurons." in: Cells, Vol. 8, Issue 12, (2019) (PubMed).

Pansarasa, Bordoni, Drufuca, Diamanti, Sproviero, Trotti, Bernuzzi, La Salvia, Gagliardi, Ceroni, Cereda: "Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms." in: Disease models & mechanisms, Vol. 11, Issue 3, (2018) (PubMed).

Moore, Blachere, Fak, Park, Sawicka, Parveen, Zucker-Scharff, Moltedo, Rudensky, Darnell: "ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity." in: eLife, Vol. 7, (2018) (PubMed).

Wang, Grunseich, Fox, Burdick, Zhu, Ravazian, Hafner, Cheung: "Human proteins that interact with RNA/DNA hybrids." in: Genome research, Vol. 28, Issue 9, pp. 1405-1414, (2018) (PubMed).

Lojk, Prpar Mihevc, Bregar, Pavlin, Rogelj: "The Effect of Different Types of Nanoparticles on FUS and TDP-43 Solubility and Subcellular Localization." in: Neurotoxicity research, (2017) (PubMed).

Stoica, Paillusson, Gomez-Suaga, Mitchell, Lau, Gray, Sancho, Vizcay-Barrena, De Vos, Shaw, Hanger, Noble, Miller: "ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations." in: EMBO reports, Vol. 17, Issue 9, pp. 1326-42, (2016) (PubMed).